Skip to main content

Animations

MJFF Publications

3931 - 3940 of 8808 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2023
  • 2022
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: Motor- and cognition-related safety of pimavanserin in patients with Parkinson's disease psychosis
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2022.919778
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Druggable transcriptomic pathways revealed in Parkinson’s patient-derived midbrain neurons
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00400-0
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Targeting the inflammasome in Parkinson’s disease
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2022.957705
    Citation Count: 19
  • Summary Details
    OPEN
    Title: The impact of harmonization on radiomic features in Parkinson’s disease and healthy controls: A multicenter study
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2022.1012287
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Elevated Plasma Phosphorylated Tau 181 in Amyotrophic Lateral Sclerosis
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.26462
    Citation Count: 37
  • Summary Details
    OPEN
    Title: Neuromelanin and T2*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00405-9
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Border-associated macrophages mediate the neuroinflammatory response in an alpha-synuclein model of Parkinson disease
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-023-39060-w
    Citation Count: 87
  • Summary Details
    OPEN
    Title: Alpha synuclein, the culprit in Parkinson disease, is required for normal immune function
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.celrep.2021.110090
    Citation Count: 83
  • Summary Details
    OPEN
    Title: Substitution of PINK1 Gly411 modulates substrate receptivity and turnover
    Journal Name: Autophagy
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1080/15548627.2022.2151294
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Sensitivity to Change and Patient‐Centricity of the Unified Multiple System Atrophy Rating Scale Items: A Data‐Driven Analysis
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28993
    Citation Count: 14
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.